|Researchers from stem cell company, CellCure Neurosciences |
believe they have developed a new treatment for age-related
macular degeneration in the eyes.
An Israeli company is using a new stem cell technology to save the sight of aging baby boomers by replacing diseased cells with new ones.
Are "granny glasses" a thing of the past? Israeli company CellCure Neurosciences has developed a new stem cell technology for the treatment of age-related eyesight deterioration, which would replace diseased cells with fresh new ones. The innovative treatment, which is unprecedented in the medical field, would not just improve deteriorating eyesight; rather those who benefit from the treatment will feel as if they have a new set of eyes.
New cells halt disease
More than eight million people in the US and many millions more worldwide, suffer from age-related macular degeneration, the main cause of visual impairment in people over 50. The dry form of this disease, which CellCure plans to treat, affects the ability to see fine details. Thus, company CEO Charles Irving explains, "Those who are unfortunate enough to have this disease cannot read, drive, or see the faces of their grandchildren."
Age-related macular degeneration begins in the retina, when retinal pigment epithelial (RPE) cells begin to die. RPE cells are caretakers of the photo-receptors - the cells in the retina that enable the eye to see light and dark. Currently there is no drug treatment for this disease, which typically progresses gradually over time. -- I.C. Meyer, Israel Ministry of Foreign Affairs
To see the complete article, click here.